Bringing the fundamentals into focus…
Back to Legend Biotech Corporation
How Legend Biotech Corporation stacks up
LEGN · against 254 other Healthcare companies of similar size
Profitability
23/ 100
Near the bottom of its peers.
Ranked #207 of 255 · scores higher than 19% of peers
Bars: peers in each 10-point band of the profitability score22 peers with a profitability score of 20–29, including LEGN · Click a bar to see the companies
Why profitability scores 23?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 81% of peers. Return on invested capital: -25.7% vs peer median 4.7%
- a lower return on assets: weaker than 79% of peers. Return on assets: -17.1% vs peer median 1.7%
- a thinner operating margin: weaker than 76% of peers. Operating margin: -13.3% vs peer median 7.1%
Metric by metric
Position: dot = LEGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LEGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 246 reported | -25.7% | 8.4% | 14% | 33% | |
| Operating marginHigher is better · 233 reported | -13.3% | 11.0% | 14% | 33% | |
| Return on assetsHigher is better · 241 reported | -17.1% | 3.4% | 17% | 33% | |
| Return on equityHigher is better · 237 reported | -8.1% | 7.5% | 28% | Context only | |
| Gross marginHigher is better · 262 reported | 56.6% | 48.0% | 62% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around LEGN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 4 | 3.8B USD | 99 | 71 | |
| 202 | 3.3B USD | 26 | 44 | |
| 202 | 6.6B USD | 26 | 45 | |
| 205 | 4.1B USD | 25 | 39 | |
| 205 | 5.6B USD | 25 | 53 | |
| 207 | 4.2B USD | 23 | 44 | |
| 208 | 34.9B CNY (≈$4.9B) | 22 | 16 | |
| 208 | 2.2B USD | 22 | 32 | |
| 208 | 4.1B USD | 22 | 42 | |
| 211 | 7.3B USD | 21 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score